Total Payments
$6,200
2024 Payments
$1,025
Companies
38
Transactions
398
Medicare Patients
3,174
Medicare Billing
$285,858
Payment Breakdown by Category
Food & Beverage$6,025 (97.2%)
Research$125.00 (2.0%)
Education$49.76 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,025 | 394 | 97.2% |
| Unspecified | $125.00 | 1 | 2.0% |
| Education | $49.76 | 3 | 0.8% |
Payments by Type
General
$6,075
397 transactions
Research
$125.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $775.67 | 40 | $0 (2024) |
| Indivior Inc. | $570.00 | 20 | $0 (2024) |
| ABBVIE INC. | $521.96 | 42 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $477.68 | 37 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $436.96 | 32 | $0 (2018) |
| Allergan Inc. | $360.93 | 35 | $0 (2019) |
| Ardelyx, Inc. | $293.03 | 16 | $0 (2024) |
| QOL Medical, LLC | $246.17 | 11 | $0 (2024) |
| UCB, Inc. | $228.53 | 14 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $210.56 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,025 | 50 | QOL Medical, LLC ($186.01) |
| 2023 | $814.62 | 51 | Ardelyx, Inc. ($192.18) |
| 2022 | $86.71 | 5 | GlaxoSmithKline, LLC. ($36.62) |
| 2021 | $86.71 | 5 | AbbVie Inc. ($49.80) |
| 2020 | $304.94 | 22 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($167.56) |
| 2019 | $1,315 | 78 | Indivior Inc. ($357.84) |
| 2018 | $1,529 | 105 | Synergy Pharmaceuticals Inc ($276.96) |
| 2017 | $1,038 | 82 | Synergy Pharmaceuticals Inc ($160.00) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: OUD | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: GI | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/04/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $30.72 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/17/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Gastroenterology | ||||||
| 08/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.50 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: GASTROENTEROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information | Indivior Inc. | $125.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 505 | 720 | $114,140 | $45,103 |
| 2022 | 19 | 724 | 996 | $176,178 | $82,412 |
| 2021 | 17 | 750 | 1,124 | $192,030 | $86,503 |
| 2020 | 22 | 1,195 | 1,629 | $204,353 | $71,840 |
Total Patients
3,174
Total Services
4,469
Medicare Billing
$285,858
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 236 | $58,000 | $21,387 | 36.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 34 | 98 | $26,950 | $9,184 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $8,600 | $5,645 | 65.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $4,375 | $2,864 | 65.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 37 | $4,255 | $2,487 | 58.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 35 | 38 | $1,900 | $1,281 | 67.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 53 | 72 | $1,800 | $677.70 | 37.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 57 | $5,070 | $532.87 | 10.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 21 | 25 | $500.00 | $405.00 | 81.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 14 | $1,190 | $389.48 | 32.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 67 | 75 | $1,500 | $249.57 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 256 | $64,155 | $22,889 | 35.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 56 | 123 | $33,825 | $11,438 | 33.8% |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | Office | 2022 | 26 | 26 | $13,000 | $9,382 | 72.2% |
| Q0222 | Injection, bebtelovimab, 175 mg | Office | 2022 | 26 | 26 | $7,183 | $7,039 | 98.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $10,225 | $6,883 | 67.3% |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | Office | 2022 | 12 | 12 | $6,000 | $5,644 | 94.1% |
| 99358 | Extended patient service without direct patient contact, first hour | Office | 2022 | 42 | 66 | $11,814 | $5,355 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $5,775 | $3,934 | 68.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 52 | $7,135 | $3,443 | 48.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $3,300 | $1,870 | 56.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 26 | 27 | $1,350 | $935.46 | 69.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 64 | 86 | $2,145 | $824.63 | 38.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 30 | 32 | $1,120 | $777.92 | 69.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,890 | $572.39 | 30.3% |
About Dr. P Canchis, MD
Dr. P Canchis, MD is a Internal Medicine healthcare provider based in Johnston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518018811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. P Canchis, MD has received a total of $6,200 in payments from pharmaceutical and medical device companies, with $1,025 received in 2024. These payments were reported across 398 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,025).
As a Medicare-enrolled provider, Canchis has provided services to 3,174 Medicare beneficiaries, totaling 4,469 services with total Medicare billing of $285,858. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Johnston, RI
- Active Since 01/15/2007
- Last Updated 04/12/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518018811
Products in Payments
- LINZESS (Drug) $448.27
- Trulance (Drug) $436.96
- SUBLOCADE (Drug) $412.08
- SHINGRIX (Biological) $370.56
- IBSRELA (Drug) $293.03
- XIFAXAN (Drug) $242.30
- TRULANCE (Drug) $235.38
- Cimzia (Drug) $228.53
- VOQUEZNA (Drug) $210.56
- SUCRAID (Drug) $186.01
- Creon (Drug) $168.52
- TRELEGY ELLIPTA (Drug) $141.58
- ANORO (Drug) $138.05
- SUBOXONE (Drug) $125.00
- Kerendia (Drug) $113.98
- MOUNJARO (Drug) $110.31
- LYRICA (Drug) $105.34
- BREO (Drug) $97.64
- Wegovy (Drug) $95.72
- Amitiza (Drug) $84.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Johnston
Kathleen Gordon, Do, DO
Internal Medicine — Payments: $20,027
Internal Medicine $20,027
Leah Brandon, Do, DO
Internal Medicine — Payments: $9,373
Internal Medicine $9,373
Ms. Stephanie Drainville, Pa-C, PA-C
Internal Medicine — Payments: $7,953
Internal Medicine $7,953
Dr. Kiley Toder, M.d, M.D
Internal Medicine — Payments: $7,232
Internal Medicine $7,232
Dr. Vito Ferri, D.o, D.O
Internal Medicine — Payments: $1,220
Internal Medicine $1,220
William Beliveau, M.d, M.D
Internal Medicine — Payments: $899.97
Internal Medicine $899.97